Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026Translational PsychiatryOpen Access

Toward precision psychiatry: integrating pharmacogenomics and multimodal clinical data for personalized antidepressant response prediction

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRuoxi WangFWFei WuXZXuequan Zhu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6aabb7275f706d05830e603bhttps://doi.org/10.1038/s41398-026-04440-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review2025 · 3 citations
  2. 2The clinical value of pharmacogenomics in the pharmacotherapy of common psychiatric disorders: a macroscopic analysis based on real-world data2026
  3. 3Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system2026 · 1 citations
  4. 4Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis2024 · 24 citations
  5. 5Predictive Pharmacogenetic Testing in Psychiatry: Pros and Cons2024 · 2 citations